Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07710781
What this trial is testing

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaAcute Lymphoblastic Leukemia+9 more
Ossium Health, Inc. 300
Testing effectiveness (Phase 2)Study completedNCT02638467
What this trial is testing

Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy

Who this might be right for
LeukemiaMyelogenousChronic+1 more
University of Milano Bicocca 2
Not applicableEnded earlyNCT02360111
What this trial is testing

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 3
Not applicableStudy completedNCT05968963
What this trial is testing

Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationMyelodysplastic SyndromesLeukemia, Myeloid, Acute+2 more
University of Miami 61
Not applicableStudy completedNCT06000306
What this trial is testing

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

Who this might be right for
Measurable Residual Disease
Zhejiang University 192
Testing effectiveness (Phase 2)Ended earlyNCT01279616
What this trial is testing

A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Nationwide Children's Hospital 8
Not applicableUnknownNCT02829216
What this trial is testing

Graft-versus-host Disease Associated Myelosuppression

Who this might be right for
Abnormal HematopoiesisAllogenic DiseaseGraft vs Host Disease
Technische Universität Dresden 50
Testing effectiveness (Phase 2)Study completedNCT01220895
What this trial is testing

Alternate Donor Study of Pre-Emptive Cellular Therapy

Who this might be right for
Cytomegalovirus Infection
Cell Medica Ltd 52
Large-scale testing (Phase 3)Study completedNCT05149365
What this trial is testing

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

Who this might be right for
Acute-graft-versus-host DiseaseAllogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 190
Not applicableNot Yet RecruitingNCT07010068
What this trial is testing

Nutritional Support With TGF-β2 Food for Special Medical Purposes (TGF-β2 FSMP) in Adult Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for the Prevention of Malnutrition: a Prospective, Randomized, Multicenter Study

Who this might be right for
Malnutrition (Calorie)Stem Cell Transplant Complications
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 214
Very early researchLooking for participantsNCT06735690
What this trial is testing

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
City of Hope Medical Center 15
Large-scale testing (Phase 3)Study completedNCT05763823
What this trial is testing

Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)WithdrawnNCT02724904
What this trial is testing

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma

Who this might be right for
Lymphoma
Massachusetts General Hospital
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT00750126
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Solid TumorsHematologic Neoplasms
University Hospital, Clermont-Ferrand 30
Large-scale testing (Phase 3)Study completedNCT01503515
What this trial is testing

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Who this might be right for
Fungal InfectionHematopoietic and Lymphoid Cell Neoplasm
Children's Oncology Group 292
Testing effectiveness (Phase 2)UnknownNCT04593368
What this trial is testing

Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Antibiotic Resistant Strain
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Not applicableUnknownNCT00563108
What this trial is testing

Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Hospital Authority, Hong Kong 60
Testing effectiveness (Phase 2)Ended earlyNCT04205240
What this trial is testing

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Srinivas Devarakonda 1
Not applicableNot Yet RecruitingNCT07034755
What this trial is testing

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Chimeric Antigen Receptor T-cell
The Affiliated Hospital of Xuzhou Medical University 20
Next Page
35